Nemaline Myopathy Clinical Research Network (NM-CTRN)

Part of paid clinical trials in Palo Alto, California.

Sponsor
Stanford University
Study ID
NCT06774703
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Nemaline Myopathy

Eligibility Criteria

Sex
ALL
Age
0 Years - 18 Years
Healthy Volunteers
Not accepted

Study Details

The goal of this study is to establish a research network to help define the natural disease history and clinical outcome measures for Nemaline Myopathy (NM).

Key Dates

Start date
Jan 31, 2025
Status verified
Jan 2025
Primary completion
Dec 31, 2029
Completion
Dec 31, 2029

Study Design

Enrollment
50 participants (estimated)

Arms

  • Arm: Individuals with Nemaline Myopathy
    All participants in the study will have a diagnosis of Nemaline Myopathy, with either a pathogenic or likely pathogenic mutation in ACTA1 (AD) or NEB (AR). Participants can be either ambulatory or non-ambulatory and must be between the ages of 0-18.

Primary Outcome Measure

Validate the change over 36 months using the Alberta Infant Motor Scale (AIMS) Score [ Time Frame: 36 months ]

Central Contacts

Locations (5)

FacilityCityStateZIPSite coordinators
Stanford University/Lucile Packard Children's HospitalPalo AltoCalifornia94304
Sarah Ismail, BSc
650-460-4596
Carolina Tesi-Rocha, MD
Tina Duong, PhD, PT
John W Day, MD, PhD
National Institute of HealthBethesdaMaryland20892
Christopher Mendoza
Carsten Bonnemann, MD
Boston Children's HospitalBostonMassachusetts02115
Aleah Pagan, BA
617-919-7498
Alan Beggs, PhD
Leslie Hayes, MD
St Jude Children's Research HospitalMemphisTennessee38105
Jean Laboe, MSN, RN
901-595-1693
Richard Finkel, MD
UT Southwestern Medical Centre/Children's Health DallasDallasTexas75207
Holly Lawrence, CCRC
214-456-9561
Kaitlin Batley, MD

Find similar trials in Palo Alto, CA

Related Studies